IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-07490-6.html
   My bibliography  Save this article

Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems

Author

Listed:
  • Qingxin Yao

    (National Center for Nanoscience and Technology
    University of Chinese Academy of Sciences)

  • Feng Lin

    (Peking University
    Peking University)

  • Xinyuan Fan

    (Peking University)

  • Yanpu Wang

    (Peking University)

  • Ye Liu

    (National Center for Nanoscience and Technology)

  • Zhaofei Liu

    (Peking University)

  • Xingyu Jiang

    (National Center for Nanoscience and Technology
    University of Chinese Academy of Sciences)

  • Peng R. Chen

    (Peking University
    Peking University)

  • Yuan Gao

    (National Center for Nanoscience and Technology
    University of Chinese Academy of Sciences)

Abstract

Adverse drug reactions (ADRs) restrict the maximum doses applicable in chemotherapy, which leads to failure in cancer treatment. Various approaches, including nano-drug and prodrug strategies aimed at reducing ADRs, have been developed, but these strategies have their own pitfalls. A renovated strategy for ADR reduction is urgently needed. Here, we employ an enzymatic supramolecular self-assembly process to accumulate a bioorthogonal decaging reaction trigger inside targeted cancer cells, enabling spatiotemporally controlled, synergistic prodrug activation. The bioorthogonally activated prodrug exhibits significantly enhanced potency against cancer cells compared with normal cells. This prodrug activation strategy further demonstrates high tumour inhibition efficacy with satisfactory biocompatibility, pharmacokinetics, and safety in vivo. We envision that integration of enzymatic and bioorthogonal reactions will serve as a general small-molecule-based strategy for alleviation of ADRs in chemotherapy.

Suggested Citation

  • Qingxin Yao & Feng Lin & Xinyuan Fan & Yanpu Wang & Ye Liu & Zhaofei Liu & Xingyu Jiang & Peng R. Chen & Yuan Gao, 2018. "Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems," Nature Communications, Nature, vol. 9(1), pages 1-9, December.
    • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07490-6
    DOI: 10.1038/s41467-018-07490-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-07490-6
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-018-07490-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yawen You & Qingqing Deng & Yibo Wang & Yanjuan Sang & Guangming Li & Fang Pu & Jinsong Ren & Xiaogang Qu, 2022. "DNA-based platform for efficient and precisely targeted bioorthogonal catalysis in living systems," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    2. Yin Chen & Peng Gao & Lu Huang & Xing Tan & Ningling Zhou & Tong Yang & Hua Qiu & Xin Dai & Sean Michael & Qiufen Tu & Nan Huang & Zhihong Guo & Jianhua Zhou & Zhilu Yang & Hongkai Wu, 2021. "A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent," Nature Communications, Nature, vol. 12(1), pages 1-16, December.
    3. Xinyu He & Jie Li & Xinxin Liang & Wuyu Mao & Xinglong Deng & Meng Qin & Hao Su & Haoxing Wu, 2024. "An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction," Nature Communications, Nature, vol. 15(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07490-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.